Philip is a senior consulting leader and consumer industry strategist, helping some of the world’s leading consumer goods and retail companies identify and capture opportunities for growth.
He brings 20 years of strategy and insights experience across Europe, the Middle East, Africa and Asia-Pacific, with deep expertise across the consumer economy, spanning food & beverages, foodservice, beauty & personal care, household products, and consumer health.
His expertise includes market sizing and forecasting, competitive analysis, consumer trends, innovation, and new market entry. He has worked with senior executives across multiple markets to navigate complex challenges, identify new opportunities, and translate insight into strategies that deliver business impact.
Prior to joining GlobalData in 2016, he spent 12 years at Accenture and Zenith Global.
Tim Collard is Senior Vice President of Sales at TRI, where he has spent eight years helping Sponsors and CROs get more value from Risk-Based Quality Management (RBQM). He partners with pharma, biotech, and CRO teams to implement OPRA, TRI’s Intelligent RBQM platform, so it fits their existing processes and drives more efficient trials with stronger data quality and patient safety. Tim brings a practical, client-first view of what makes RBQM work in the real world.
Christian Schröder is Head of Business Development – Financial Services at mobile.de and brings more than 15 years of experience in business development, e-commerce, automotive financing, and digital business models. Throughout his career, he has held leadership positions at mobile.de, heycar and PayPal. Focusing on driving growth and developing successful partnerships.
Luke Outcault is the Manager of Clinical Drug Supply and Logistics at Regeneron Pharma, where he currently oversees the Investigational Product Supply Chain initiation, management, and close out across numerous phase 1, 2, and 3 trials. With over 10 years of experience in the biotechnology sector, Luke specializes in study forecasting, clinical packaging and labeling, and cross-functional process design. Throughout his career, he has continuously pushed to bridge the gap between Clinical Operations and Manufacturing. Luke holds an Masters in Healthcare Admin from the University of Miami and a green belt in Lean Six Sigma.
Marsha Meron is a Senior Manager of Clinical Drug Supply & Logistics, Ancillary Supply Management at Regeneron, where she leads global ancillary supply strategies that support the successful execution of clinical trials. With extensive experience in supply chain operations, sourcing, logistics, and vendor management, she specializes in developing efficient and compliant supply solutions for complex global studies. Throughout her career, Marsha has focused on optimizing supply chain processes, driving cross-functional collaboration, and implementing innovative approaches that balance patient needs, operational efficiency, and cost management. She works closely with Clinical Operations, Global Development, Procurement, and external partners to ensure the timely delivery of critical ancillary supplies worldwide. Marsha is also passionate about process improvement, standardization, and leveraging data-driven insights to enhance clinical trial supply performance
Keaton Fonvielle is Head of Client Services at Atreo, where she leads client services strategy, project management, and operational delivery. She brings more than 14 years of experience in RTSM across both CRO and technology organizations, with a background in project delivery, client leadership, team development, and operational transformation. Keaton is particularly passionate about leveraging technology to make peoples’ lives better – creating positive experiences for clients, internal teams, and most importantly, patients.
Priya Mann is a Business Development Manager at BD (Becton Dickinson), with 9+ years of commercial life-science experience. Currently working with pharmaceutical organisations across Europe to advance biospecimen collection, cell preservation, and biomarker-enabled clinical research. She specializes in clinical research partnerships that support biomarker-driven drug development and precision medicine initiatives.
Jen Blankenship is the Director of Science at VivoSense, where she leads scientific strategy and supports the development and implementation of digital measures in clinical research. She works closely with pharmaceutical sponsors and cross-functional teams to design studies that integrate wearable sensors and digital measures in ways that are scientifically meaningful and fit for purpose. In her role, Jen helps sponsors evaluate how digital measures can strengthen clinical development programs, from early exploratory research through later-stage studies, with a focus on generating interpretable evidence that can inform clinical development decisions.
Åsa leads TFS HealthScience’s Internal Medicine and Neuroscience teams and brings 30 years of experience in life sciences and pharmaceutical research. She has worked with pharmaceutical and biotech companies on global studies across all development phases and a wide range of indications, including asthma, COPD, diabetes, kidney diseases, wound healing, hematology, migraine, Alzheimer’s and Parkinson’s disease. She also has extensive experience with regulatory submissions to the FDA, EMA and other regulatory authorities worldwide.
Dr. Šime Pervan – Delivery Owner & Internal Project Lead, SMYLE Project (Exxeta)
With over 25 years of experience as a project manager (predictive, hybrid & agile) in the automotive industry, Dr. Šime Pervan is a seasoned leader skilled in guiding teams to achieve project goals. As a servant leader, he is dedicated to developing high-performing project teams and communicating effectively with clients, management, and contractors. Since December 2021, he has served as Delivery Owner and internal Project Lead at Exxeta for the SMYLE project, driving the integration of a new contract management system for Mercedes-Benz Leasing Deutschland (MBLD) in close collaboration with CMS provider Alfa.